Ask AI

Regional Strategies for a Global Challenge: Equipping Learning Networks to Elevate the Multidisciplinary Management of Patients With R/R CLL/SLL

Enhance your understanding of emerging clinical evidence and expert recommendations for novel targeted therapies currently used to manage relapsed/refractory CLL/SLL to plan individualized treatment sequences, implement multidisciplinary strategies, and optimize patient outcomes through expert-written ClinicalThought commentaries, an Interactive Decision Support Tool, downloadable patient tool kits, and downloadable slides with notes.

Share

Program Content

Events

Activities

Advancing Care in RR CLL
A Global Call to Action for Advancing Care in Relapsed/Refractory CLL 
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 08, 2026

Expires: July 07, 2026

Activities

Versorgung rezidivierte refraktäre CLL verbessern
Eine globale Initiative zur Verbesserung der Versorgung bei rezidivierter/refraktärer CLL
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 12, 2026

Améliorer les soins LLC récidivante réfractaire
Appel mondial à l'action pour améliorer les soins dans le traitement de la LLC récidivante ou réfractaire
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 12, 2026

Optimizando el manejo de LLC recidivante refractaria
Llamamiento a la acción para mejorar resultados en el manejo de la leucemia linfocítica crónica (LLC) recidivante/refractaria al tratamiento oncológico  
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 12, 2026

Progetto internazionale cura LLC recidivata refrattaria
Una iniziativa internazionale per migliorare la cura della LLC recidivata/refrattaria
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 12, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Lymphoma Coalition.

Supporters

Supported by educational grants from Lilly and Merck Sharp & Dohme LLC.

Lilly

Merck Sharp & Dohme, LLC

Partners

Lymphoma Coalition

ProCE Banner